Sichuan Biokin Pharmaceutical Co.,Ltd.

Research Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS) on Bullrun: market cap CNY 96.56B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 96.56B.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 96.56Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CNY.

About Sichuan Biokin Pharmaceutical Co.,Ltd.

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, manufacture, and sale of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.

ETFs that hold Sichuan Biokin Pharmaceutical Co.,Ltd.

US-listed ETFs

Sichuan Biokin Pharmaceutical Co.,Ltd. is held by 24 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:

ETFWeightFee
Vanguard Total International Stock Index Fund ETF Shares (VXUS)<0.01%0.05%
Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO)0.01%0.06%
Vanguard Total World Stock Index Fund ETF Shares (VT)<0.01%0.06%
iShares MSCI ACWI ETF (ACWI)<0.01%0.32%
iShares MSCI ACWI ex U.S. ETF (ACWX)<0.01%0.32%
Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU)<0.01%0.04%
iShares Core MSCI Total International Stock ETF (IXUS)<0.01%0.07%
Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)0.08%0.65%

Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.

Related stock research

China stocks China Healthcare stocks A-Z stock index

Other Healthcare stocks

Shandong Dong-Ee Jiao Co Ltd (000423.SZ) Livzon Pharmaceutical Group Inc (000513.SZ) Yunnan Baiyao Group Co., Ltd. (000538.SZ) Jilin Aodong Pharmaceutical Group Co., Ltd. (000623.SZ) Chang Chun High and New Technology Industry (Group) Inc. (000661.SZ) Apeloa Pharmaceutical Co., Ltd. (000739.SZ) Huadong Medicine Co Ltd (000963.SZ) China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999.SZ) Zhejiang NHU Co Ltd (002001.SZ) Jiangsu Nhwa Pharmaceutical Co Ltd (002262.SZ) Shijiazhuang Yiling Pharmaceutical Co Ltd (002603.SZ) Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)

Frequently asked questions

What is Sichuan Biokin Pharmaceutical Co.,Ltd.'s market cap?

Sichuan Biokin Pharmaceutical Co.,Ltd.'s market capitalization is CNY 96.56B.

What does Sichuan Biokin Pharmaceutical Co.,Ltd. do?

Sichuan Biokin Pharmaceutical Co.,Ltd. engages in the research and development, manufacture, and sale of biomedicine in the fields of antibody drug conjugate, guidance navigation and control, and antibody radionuclide conjugate in China and internationally. It offers anesthesia, parenteral nutrition, anti-infectives, pediatrics, and traditional Chinese medicines. The company was founded in 1996 and is headquartered in Chengdu, China.